On December 3rd, according to informed sources, Novo Nordisk's Indian team has been pushing the company to launch its popular weight loss drug Wegovy earlier in India due to concerns about falling behind its competitor Eli Lilly in the huge potential market. Novo Nordisk previously stated that once approved by regulatory authorities and with sufficient supply, Wegovy may enter India in 2026. But recently, Novo Nordisk's Indian team proposed to advance the listing of Wegovy in India to next year. (Reuters)